Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will ...

The MarketWatch News Department was not involved in the creation of this content.-- Novel combinatorial oral therapy extended median remaining lifespan in adult mice by 33% compar ...

"RNA modifications are central to how cells respond to their environment," said Gudrun Stengel, Ph.D., Chief Executive Officer of Alida Biosciences. "With EpiPlex Tri-Mod, we move beyond method ...

According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 ...

According to MarketsandMarkets, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 to USD 5.93 billion ...

GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.

As of spring 2026, a cancer drug that has spent years in clinical development as a Wnt/beta-catenin pathway blocker has been ...

Advanced genetic testing could help erase significant disparities in breast cancer survival rates between white and black ...

Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...

A new technology that analyzes gene expression in cells reveals new insights into immune cell activity. This new single-cell ...

Fred Hutch at AACR: Colorectal cancer and glyphosate exposure, potential therapeutic targets for ovarian cancer, a new ...